-
1 Comment
China Medical & HealthCare Group Limited is currently in a long term downtrend where the price is trading 5.2% below its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
China Medical & HealthCare Group Limited's total revenue sank by 74.3% to $473M since the same quarter in the previous year.
Its net income has dropped by 3317.6% to $-70M since the same quarter in the previous year.
Finally, its free cash flow fell by 144.3% to $-54M since the same quarter in the previous year.
Based on the above factors, China Medical & HealthCare Group Limited gets an overall score of 1/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | BMG2133H1016 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Beta | 0.62 |
|---|---|
| Market Cap | 845M |
| Target Price | None |
| Dividend Yield | 2.6% |
| PE Ratio | 26.0 |
Tian An Medicare Limited, an investment holding company, primarily operates hospitals in the People's Republic of China and Hong Kong. It operates through six segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. The company also involved in property development of independent living units and project management of health campus with a focus on eldercare and retirement community including elderly nursing home, service apartments, independent living units and commercial area comprising shopping mall, retail shops, and club hall facilities. In addition, it develops and sells properties and lands; leases residential and office properties; and provides loan financial and healthcare services, as well as trading of securities listed in overseas exchange. The company was formerly known as China Medical & HealthCare Group Limited and changed its name to Tian An Medicare Limited in April 2024. The company was incorporated in 1989 and is headquartered in Wan Chai, Hong Kong. Tian An Medicare Limited is a subsidiary of Tian An China Investments Company Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0383.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
